News
Celebrating the 24th Anniversary
Friday, December 7, 2018
Author: CIM
Source: CIM
External Source: https://www.facebook.com/pg/cim.cuba/posts/
Today we celebrate 24 years of our creation and remember with great emotion the words of Fidel Castro, which later became our mission: ... "I must add that there are very few centers in the world like this one, it is a worldwide center in its construction, in its cleanliness, in its equipment, they are the most modern, but above all, there is something in which I I am sure that nobody will beat us in the world and it is in the quality of men and women who go to work, or who are already working in this center "... ... "It is a pride during this special period to inaugurate this center, which is not a luxury, it is a promise of health and wellbeing for our people, it is a promise of income for our economy ..." There are many reasons we have to celebrate and for which a meeting has been organized with doctors and cancer patients, who will have the opportunity to share with everyone how the use of our products has impacted their lives. Also, we will inaugurate a painting mural dedicated to our work, entitled METÁFORA, its author Sandra Delgado, which will mean a starting point to mark the beginning of year 25 of the CIM, which we will be celebrating throughout 2019. Congratulations to all who have been part of
Comment
Comments
Spot
Video
Bulletin CIM
¡Stay informed of our latest news!
Frequent Questions
How can I access the therapeutic vaccine against lung cancer CIMAvax-EGF?
CIMAvax EGF ® is a therapeutic vaccine registered in Cuba (developed by the Center of Molecular Immunology (CIM), for advanced lung cancer. This therapeutic vaccine has a health history in the indication: Advanced non-small cell lung cancer (NSCLC) stage IIIb and IV, after the first line of chemotherapy. It is in this condition and type of lung cancer that the greatest clinical benefit is obtained in terms of increased survival and improved quality of life, as well as a broad safety profile in treated patients. This vaccine is not recommended for other types of cancer, apart from NSCLC, the tumor must be primary pulmonary, because we have no evidence of efficacy to date. It is necessary to know the histology and tumor stage of the patient, since CIMAvax EGF ® is only registered for non-small cell lung cancer of advanced stage IIIb and IV cells (NSCLC), in other types of tumors we have no evidence of clinical efficacy .
Questions of Interest:
Position of CIM for CIMAvax EGF®:
The Center for Molecular Immunology (CIM) is the center where it develops, produces and markets this medicine among other biotechnological products. This institution does not offer treatments to patients directly, nor does it inform about the price of the products they produce.
Foreign patients should contact the Cuban Medical Services who will evaluate each case if they are susceptible to treatment with these vaccines and receive it within a comprehensive program of patient care with commercial value.
You can contact them at these addresses:
Cuban Medical Services.
Web Page: www.smcsalud.cu; E-mail: smc@smcsalud.cu
Phones: (537) 209-0977
Fax: (537) 203-1590
At the International Clinic La Pradera:
Phones (537) 2737467 ext. 403
Commercial: 72731441
Relacinternac@cislapradera.cu
If you want a treatment outside of Cuba:
Paraguay
Laboratorio Libra Paraguay S.A
Dirección: Pedro Ciancio 1443 entre Santiago y San Cosme B Jara Asunción Persona de Contacto: Sr. Pablo Moreira Gerente Comercial
Correo electrónico: pmoreira@lablibra.com
Teléfono: (595-21) 228 370
Móvil: (595) 986 679300
Colombia
LABORATORIOS DELTA
Sr. Alejandro Castaño.
Gerente general
Alejandrodelta@deltamedecine.com
Tel: + 57-4-334 40 33
Móvil: +57 - 311 301 8257
Skype: Alejandrodelta
Www.deltamedicine.com
Cra.46 # 19 sur 117
Medellín, Colombia, América del Sur
Argentina
Laboratorio Elea Phoenix S.A.
Sanabria 2353 (C1417AZE), Ciudad Autónoma de Buenos Aires, Argentina
Tel. (5411) 4379 4300 (int. 1266)
www.elea.com
Director médico Dr. Matias DEPRATI
Email: DEPRATIM@elea.com
Kazajistán
LLP UM-Pharma
УМ-Фарм
050033, Almaty, Khodzhanova street, 13 house, 69
CEO. Alina Ilimbayeva
+7 701 715 6000
Bosnia Herzegovina
VAMA d.o.o.
Kraljice Natalije 46
11.000 Beograd
Tel: +381 11 36 28 433
www.vama.rs
CEO. Mr. Zoran Vujovic.
Si necesita cualquier información adicional, no dude en contactarnos.
Saludos cordiales.